$2.17 Billion is the total value of Alphabet Inc.'s 26 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 4.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JD | JD com Incspon adr cl a | $815,648,000 | +48.6% | 13,553,474 | 0.0% | 37.64% | +4.5% | |
| LYFT | Sell | Lyft Inc | $423,469,000 | +22.9% | 12,828,509 | -0.0% | 19.54% | -13.5% |
| DXCM | Dexcom Inc | $326,623,000 | +50.6% | 805,681 | 0.0% | 15.07% | +5.9% | |
| ONEM | 1Life Healthcare Inc | $224,572,000 | +100.1% | 6,183,154 | 0.0% | 10.36% | +40.8% | |
| RCUS | Arcus Biosciences Inc | $124,932,000 | +78.2% | 5,049,786 | 0.0% | 5.77% | +25.4% | |
| SDGR | Schrodinger Inc | $41,089,000 | +112.4% | 448,722 | 0.0% | 1.90% | +49.4% | |
| WORK | Slack Technologies Inc. | $40,410,000 | +15.8% | 1,299,771 | 0.0% | 1.86% | -18.5% | |
| MGTA | Magenta Therapeutics Inc | $25,077,000 | +19.6% | 3,339,138 | 0.0% | 1.16% | -15.9% | |
| RAPT | RAPT Therapeutics Inc | $24,262,000 | +36.4% | 836,059 | 0.0% | 1.12% | -4.0% | |
| BEAM | Beam Therapeutics Inc | $18,583,000 | +55.6% | 663,691 | 0.0% | 0.86% | +9.4% | |
| SPRO | Spero Therapeutics Inc | $15,052,000 | +67.4% | 1,112,473 | 0.0% | 0.70% | +17.8% | |
| FULC | Sell | Fulcrum Therapeutics Inc | $12,478,000 | +43.9% | 682,240 | -6.1% | 0.58% | +1.2% |
| SNAP | Snap Inccl a | $12,302,000 | +97.6% | 523,710 | 0.0% | 0.57% | +38.9% | |
| AUTL | Sell | Autolus Therapeutics PLCspon ads | $11,193,000 | +167.2% | 698,262 | -0.2% | 0.52% | +88.0% |
| IDYA | Ideaya Biosciences Inc | $10,703,000 | +244.9% | 753,187 | 0.0% | 0.49% | +142.2% | |
| CRTX | Cortexyme Inc | $8,756,000 | +1.5% | 189,122 | 0.0% | 0.40% | -28.6% | |
| GRTS | Gritstone Oncology Inc | $6,169,000 | +14.1% | 929,022 | 0.0% | 0.28% | -19.7% | |
| MWK | Mohawk Group Hldgs Inc | $5,797,000 | +224.8% | 1,055,954 | 0.0% | 0.27% | +129.1% | |
| CLDR | Cloudera Inc | $5,440,000 | +61.6% | 427,710 | 0.0% | 0.25% | +13.6% | |
| EVLO | Evelo Biosciences Inc | $5,196,000 | +30.5% | 1,060,495 | 0.0% | 0.24% | -8.0% | |
| ALEC | Alector Inc | $4,298,000 | +1.3% | 175,866 | 0.0% | 0.20% | -28.8% | |
| CRWD | Sell | Crowdstrike Hldgs Inccl a | $3,111,000 | -67.3% | 31,020 | -81.9% | 0.14% | -77.0% |
| UBER | Uber Technologies Inc | $1,292,000 | +11.3% | 41,585 | 0.0% | 0.06% | -21.1% | |
| DBX | Dropbox Inccl a | $284,000 | +20.3% | 13,033 | 0.0% | 0.01% | -13.3% | |
| VIR | Exit | Vir Biotechnology Inc | $0 | – | -1,666,666 | -100.0% | -3.75% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 10-Q | 2024-04-26 |
| 144 | 2024-04-26 |
| 4 | 2024-04-26 |
| 4 | 2024-04-26 |
| ARS | 2024-04-26 |
| DEF 14A | 2024-04-26 |
| DEFA14A | 2024-04-26 |
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.